This site is a resource for healthcare providers who have an interest in liver disease, especially viral hepatitis. The educational content provided here is focused on management issues. For more general information, please go to the general education part of this website.

Resources for Ontario

EAP application forms

EAP is a way to get funding for medications to treat viral hepatitis for those who don't have private insurance coverage or who do not want to pay cash for their medications. 		What's New
Getting closer to the causes of primary biliary cirrhosis
  • The TWH Liver Centre is pleased to announce a major breakthrough in our understanding of primary biliary cirrhosis (PBC), the classic autoimmune liver disease. In a close collaboration with genetics experts at Mount Sinai Hospital, also in Toronto, as well as collaborators across Canada and the US, we have published the first ever genome scan of PBC in the highly influential New England Journal of Medicine in May 2009. Indeed this is one of the first genome scans of note in liver disease per se. For more information, click here.
NIH Hepatitis B Research Network
  • The TWH Liver Centre is proud to be part of this new research network that was convened by the NIH in 2009. This group will be conducting studies on hepatitis B natural history and treatment. For more information, click here.
Toronto Liver Days:
Supported by Axcan, Gilead, Roche, Schering Research studies currently recruiting:
  • Hepatitis B with Lamivudine resistance and who have not yet had exposure to Tenofovir or have had Adefovir for less than 48 weeks.
  • Hepatitis C genotype 1, treatment-naive patients without cirrhosis for treatment with a new protease inhibitor from Boehringer Ingelheim